Core Viewpoint - Abacus Global Management is facing significant pressure as its stock price has dropped over 36% in the past month due to serious allegations from Morpheus Research regarding financial misconduct and questionable accounting practices [1][5]. Group 1: Allegations and Investigations - Morpheus Research, a new investigative group with ties to Hindenburg Research, published reports accusing Abacus of manipulating its life settlements portfolio through aggressive accounting practices, leading to inflated asset values and "fake revenue" [3][4]. - Hagens Berman, a prominent law firm, has initiated its own investigation into the claims made by Morpheus Research, urging affected shareholders to report their financial losses [2][6]. - The scrutiny intensified after Morpheus's follow-up report alleged inconsistencies in Abacus's rebuttal and introduced claims of undisclosed related-party transactions [4]. Group 2: Company Response and Stock Performance - In response to the allegations, Abacus retained independent actuarial firm Lewis & Ellis to review its balance sheet and reassure investors of compliance with accounting standards [4]. - Despite the company's efforts, including a $20 million share repurchase program aimed at restoring investor confidence, the stock has continued to trade near its 52-week low [5][6]. - The stock experienced a sharp 20% drop in a single day following the initial report from Morpheus [3].

ORLANDO, Fla., June 23, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ: ABL), a leader in the alternative asset management space, announced the public launch of their new corporate-focused commercial campaign on June 12, 2025, at their Investor Day and Longevity Summit held at Nasdaq in New York City. The campaign is centered around Abacus' positioning as a visionary leader in longevity-based asset management. In the commercial, Abacus CEO Jay Jackson depicts the ...

Investor Day & Longevity Summit June 12, 2025 abacusgm.com Disclaimer General. This presentation (this "Presentation") is provided solely for informational purposes. This Presentation is subject to update, completion, revision, verification and further amendment without notice. None of Abacus Global Management, Inc. (the "Company", "Abacus", Abacus Global Management", "we", "our", or "us") or its affiliates has authorized anyone to provide interested parties with additional or different information. The inf ...

Core Viewpoint - Abacus Global Management, Inc. is facing significant scrutiny and a decline in share price due to allegations of improper accounting practices, as detailed in two critical reports from Morpheus Research within a week [1][3][5]. Group 1: Allegations and Reports - Morpheus Research published an initial report on June 4, 2025, alleging that Abacus engaged in an "accounting scheme" by using "mark-to-model" accounting and underestimating life expectancies, leading to the creation of "fake revenue" [3][4]. - The second report from Morpheus, released on June 12, 2025, escalated the allegations by presenting new evidence of undisclosed related-party dealings and questioning the independence of the actuarial firm Lewis & Ellis, which Abacus claimed had vetted its asset valuations [5][6]. Group 2: Market Reaction - Following the initial Morpheus report, Abacus's shares experienced a decline of over 20% in a single trading day [4]. - The ongoing investigations and negative reports have led to a continued sharp decline in Abacus's share price, raising concerns among investors [6]. Group 3: Company Response - In response to the allegations, Abacus published a rebuttal on June 10, 2025, asserting that it had retained Lewis & Ellis to validate its balance sheet, claiming the firm has a "sterling reputation" [4]. - However, Morpheus's follow-up report indicated that Abacus's rebuttal was inadequate and contradicted its own SEC filings, further intensifying scrutiny on the company's financial practices [5].

Summary of Abacus Global Management Conference Call Company Overview - **Company**: Abacus Global Management - **Industry**: Asset Management, Life Insurance Policies Key Points and Arguments 1. **Business Model Evolution**: Abacus is expanding from life insurance policy sourcing to asset management and private wealth management, leveraging lifespan data and technology [1][7][10] 2. **Growth Strategy**: The company aims to control its destiny through a diversified business model, focusing on four main divisions: Abacus Asset Group, Abacus Life Solutions, ABL Tech, and Abacus Wealth Advisors [27][28][45] 3. **Financial Performance**: - Q1 2025 revenue reached $44.1 million, a 105% increase year-over-year - Adjusted net income was $17.3 million, up 158% from the previous year - Adjusted EBITDA was $24.5 million, reflecting a 111% growth [29][30][34] 4. **Capital Deployment**: $125.9 million was deployed for policy purchases through Abacus Life Solutions, with $3.1 billion in assets under management [31][32] 5. **Market Position**: Abacus is positioned as a leader in the alternative asset management space, focusing on longevity and technology-driven solutions [28][45] 6. **Acquisition Strategy**: The acquisition of Carlisle Management Company added $2 billion in assets under management and is expected to generate $30 million in recurring management fees annually [48][49] 7. **Client Base and Partnerships**: The company has established partnerships with over 30,000 independent brokers and has a growing consumer direct division fueled by digital marketing [66][67] 8. **Future Guidance**: The company projects adjusted net income for 2025 to be between $70 million and $78 million, with a goal of reaching $10 billion in assets under management in the coming years [56] Additional Important Insights 1. **Technological Integration**: ABL Tech is enhancing the company's data analytics capabilities, which supports better decision-making and risk management [51][52] 2. **Demographic Trends**: The aging population and increasing need for retirement solutions are driving demand for Abacus's services [68] 3. **Regulatory Compliance**: Abacus is now regulated by both the SEC in the U.S. and the CSSF in Luxembourg, enhancing transparency and product quality [82][83] 4. **Social Responsibility**: The company has received ESG certification, emphasizing its commitment to socially responsible investment practices [83] 5. **Market Opportunities**: There is an estimated $223 billion in life insurance policies available in the secondary market, presenting significant growth potential for Abacus [66][69] This summary encapsulates the key points discussed during the conference call, highlighting Abacus Global Management's strategic direction, financial performance, and market opportunities.

Core Viewpoint - The Schall Law Firm is investigating Abacus Global Management, Inc. for potential violations of securities laws, particularly concerning misleading statements and undisclosed information [1][2]. Group 1: Investigation Details - The investigation centers on whether Abacus issued false or misleading statements and failed to disclose critical information to investors [2]. - A report by Morpheus Research claims that Abacus changed its portfolio valuation methodology to present a more favorable financial picture, suggesting that the company is involved in an accounting scheme related to life settlements [2]. Group 2: Company Background - Abacus Global Management is identified as a SPAC (Special Purpose Acquisition Company) with a valuation of $794 million [2]. - The report also raises concerns about the methodologies used by Abacus to estimate life expectancy, indicating potential irregularities in their calculations [2]. Group 3: Legal Representation - The Schall Law Firm is reaching out to shareholders who may have suffered losses and is offering free consultations regarding their rights [3].

Core Viewpoint - Abacus Global Management strongly refutes the allegations made in a short seller's report, asserting that the claims regarding its reliance on a single life expectancy provider and inflated balance sheet valuation are incorrect [2][22]. Group 1: Response to Short Seller Allegations - The short seller's report claims that Abacus relies too heavily on Lapetus Solutions for life expectancy estimates, which the company denies, stating that it does not depend on Lapetus for portfolio valuation [2][6]. - Abacus engaged Lewis and Ellis, a third-party actuarial firm, to validate its policy balance sheet, confirming that the valuation of $449 million as of March 31, 2025, aligns closely with its own reported valuation of $446 million [9][6]. - The company emphasizes that its valuation methodology incorporates a mark-to-market approach, which is based on actual market transactions rather than solely on life expectancy estimates [12][10]. Group 2: Valuation Methodology - Abacus employs a dual valuation approach: life expectancy estimates for consumer-facing transactions and market-based valuations for balance sheet management, ensuring fair pricing and accurate asset valuation [10][11]. - The company prioritizes market reality in its trading portfolio, which allows for a more accurate reflection of asset value based on actual transaction history [20][12]. - Recent market transactions support the accuracy of Abacus's valuation model, with the company selling 226 policies for $141.4 million, closely matching the estimated balance sheet value of $139.1 million [15][16]. Group 3: Shareholder Commitment and Future Outlook - Abacus executives and shareholders collectively own approximately 46% of the outstanding shares, with a two-year lock-up period expiring on July 3, 2025, which is expected to positively impact the company's inclusion in the Russell 2000 and 3000 indices [17][19]. - The company asserts that the expiration of the lock-up period is not an opportunity for large shareholders to cash out but rather a chance to drive the company towards its next milestones [18][19]. - Abacus is committed to transparent communication with shareholders regarding any future share sales, emphasizing its long-term dedication to increasing shareholder value [20][21].

Core Insights - Bragar Eagel & Squire, P.C. is investigating potential claims against GoHealth, Inc. and Abacus Global Management, Inc. for possible violations of federal securities laws and unlawful business practices [1] GoHealth, Inc. (NASDAQ:GOCO) - The U.S. Department of Justice filed a False Claims Act complaint against GoHealth and other health insurance companies, alleging that from 2016 to at least 2021, they paid hundreds of millions of dollars in illegal kickbacks to brokers for enrollments in Medicare Advantage plans [2] - Following the DOJ's announcement, GoHealth's stock price dropped by $1.09 per share, a decline of 10.35%, closing at $9.44 per share on May 1, 2025 [2] Abacus Global Management, Inc. (NASDAQ:ABL) - Morpheus Research published a report alleging that Abacus Global Management is involved in an accounting scheme related to life settlements, which artificially inflates revenue by underestimating mortality rates [3] - In response to the report, Abacus Global's stock price fell by more than 21% [3]

SAN DIEGO, June 09, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Abacus Global Management, Inc. (NASDAQ: ABL) focused on whether Abacus Global and certain of its top executives made false and/or misleading statements and/or failed to disclose material information to investors. If you have information that could assist in the Abacus Global investigation or if you are an Abacus Global investor who suff ...

Core Viewpoint - Abacus Global Management has authorized a $20 million share repurchase program, reflecting confidence in its business model and balance sheet amidst a short attack on its stock price [1][2]. Group 1: Share Repurchase Program - The share repurchase program is effective from June 5, 2025, and will last for up to 18 months [1]. - The company may repurchase shares through various methods, including open market transactions and block trades, at its discretion based on several factors [2]. - The program is expected to be funded using cash on hand and anticipated future free cash flow [2]. Group 2: Management's Response - The CEO of Abacus stated that the current depressed share price presents a buying opportunity, supported by the new share repurchase program and employee investments totaling over $2 million [2]. - The company is committed to pursuing legal action against those responsible for the short attack [3]. Group 3: Company Overview - Abacus Global Management specializes in alternative asset management, data-driven wealth solutions, and technology innovations, focusing on longevity-based assets and personalized financial planning [8].